A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B

NCT00117676 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

382

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: TDF
DRUG: ADV
DRUG: TDF placebo
DRUG: ADV placebo
DRUG: FTC/TDF

Sponsor

Gilead Sciences